--- a
+++ b/clusters/9knumclustersv2/clust_1056.txt
@@ -0,0 +1,80 @@
+Patients with a history of stroke or intracranial hemorrhage within  months prior to registration are not eligible
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke/intracranial hemorrhage =<  months prior to registration
+History of intracranial abscess within  months prior to randomization.
+History of stroke or intracranial hemorrhage within  months prior to randomization
+History of stroke or intracranial hemorrhage within  months of first dose
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+Any history of symptomatic intracranial hemorrhage.
+Patients should not have a stroke or intracranial hemorrhage within last  months
+Patients will not be eligible if they have a history of intracranial hemorrhage in past  months
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of ischemic stroke or intracranial hemorrhage =<  days prior to pre-registration
+History of stroke/intracranial hemorrhage =<  months prior to registration
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months of the first dose of study drug
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months before the first dose of study drug
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or cerebral hemorrhage within  months
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to randomization
+History of stroke or intracranial hemorrhage within  months prior to study entry
+History of stroke or cerebral hemorrhage within  months
+History of stroke or intracranial hemorrhage within  months of screening
+No history of intracranial hemorrhage
+Relapsed/refractory MCL: History of stroke or intracranial hemorrhage within  months prior to signing the consent
+Newly diagnosed MCL: History of stroke or intracranial hemorrhage within  months prior to signing the consent
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrolment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to signing the consent.
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months before randomization.
+History of stroke or intracranial hemorrhage within  months before randomization.
+history of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or clinically significant intracranial hemorrhage within  months before first dose of study drug.
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+No stroke or intracranial hemorrhage within the last  months
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment.
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or cerebral hemorrhage within  months
+Patient has history of stroke or intracranial hemorrhage =<  months from starting study drugs
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to the first dose of study drug
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to study entry
+History of stroke or cerebral hemorrhage within  months
+Active intracranial hemorrhage
+History of stroke or intracranial hemorrhage within  months prior to the first dose of ibrutinib
+History of stroke or intracranial hemorrhage within  months prior to enrollment.
+History of stroke or intracranial hemorrhage within  months prior to enrollment.
+Subjects with a history of stroke or intracranial hemorrhage within  months prior to enrollment are not eligible
+History of stroke or intracranial hemorrhage within  months prior to randomization
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to random assignment
+History of stroke or intracranial hemorrhage within  months prior to randomization; or clinically significant cardiovascular disease
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months of screening would be exclusion for ibrutinib therapy but idelalisib would be an option
+History of stroke or intracranial hemorrhage within  months prior to registration
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+Patients with a history of known stroke or intracranial hemorrhage within  months prior to study treatment are excluded
+History of stroke or intracranial hemorrhage within  months prior to enrollment.
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+Patients with a history of intracranial hemorrhage are not eligible.
+History of stroke or intracranial hemorrhage =<  months prior to registration
+History of stroke or intracranial hemorrhage within  months prior to treatment
+History of stroke or cerebral hemorrhage within  months
+History of stroke or intracranial hemorrhage within  months of enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+EXCLUSION CRITERIA (PRIOR TO IBRUTINIB ADMINISTRATION): History of stroke or intracranial hemorrhage within  months prior to screening
+History of stroke or intracranial hemorrhage within  months prior to enrollment
+History of stroke or intracranial hemorrhage within  months of first dose